Stopping the swinging pendulum of postnatal corticosteroid use.
作者信息
Demauro Sara B, Dysart Kevin, Kirpalani Haresh
机构信息
Division of Neonatology, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Division of Neonatology, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
出版信息
J Pediatr. 2014 Jan;164(1):9-11. doi: 10.1016/j.jpeds.2013.10.020.
Abstract
摘要
相似文献
1
Stopping the swinging pendulum of postnatal corticosteroid use.停止产后使用皮质类固醇激素这一摇摆不定的做法。
J Pediatr. 2014 Jan;164(1):9-11. doi: 10.1016/j.jpeds.2013.10.020.
2
Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.在一项随机试验中，早期使用地塞米松预防极低出生体重儿死亡或慢性肺部疾病，以校正年龄 18 至 22 个月时的死亡或神经发育损伤。
J Pediatr. 2014 Jan;164(1):34-39.e2. doi: 10.1016/j.jpeds.2013.07.027. Epub 2013 Aug 27.
3
Neurodevelopmental outcome of extremely low birth weight infants with Candida infection.极低出生体重儿念珠菌感染的神经发育结局。
J Pediatr. 2013 Oct;163(4):961-7.e3. doi: 10.1016/j.jpeds.2013.04.034. Epub 2013 May 30.
4
Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.极低出生体重儿早期低剂量氢化可的松治疗后的生长及神经发育结局
Pediatrics. 2007 Jul;120(1):40-8. doi: 10.1542/peds.2006-3158.
5
Comparing the Hadlock fetal growth standard to the Eunice Kennedy Shriver National Institute of Child Health and Human Development racial/ethnic standard for the prediction of neonatal morbidity and small for gestational age.比较 Hadlock 胎儿生长标准与 Eunice Kennedy Shriver 国家儿童健康与人类发展研究所的种族/民族标准，以预测新生儿发病率和小于胎龄儿。
Am J Obstet Gynecol. 2018 Nov;219(5):474.e1-474.e12. doi: 10.1016/j.ajog.2018.08.011. Epub 2018 Aug 14.
6
Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.早期地塞米松治疗预防早产儿慢性肺病的对照试验：3年随访
Pediatrics. 2002 Jun;109(6):e85. doi: 10.1542/peds.109.6.e85.
7
An interdisciplinary bronchopulmonary dysplasia program is associated with improved neurodevelopmental outcomes and fewer rehospitalizations.多学科支气管肺发育不良项目与改善神经发育结局和减少再住院有关。
J Perinatol. 2012 Jan;32(1):33-8. doi: 10.1038/jp.2011.45. Epub 2011 May 5.
8
Neurodevelopmental and respiratory follow-up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment).对参加一项关于出生后早期和晚期全身及吸入性皮质类固醇治疗随机试验（早期皮质类固醇治疗开放研究）的英国和爱尔兰儿童进行的7岁神经发育和呼吸随访结果。
Pediatrics. 2006 Jun;117(6):2196-205. doi: 10.1542/peds.2005-2194.
9
Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone.产前暴露于地塞米松与倍他米松的极低出生体重儿的神经发育结局
Pediatrics. 2008 Feb;121(2):289-96. doi: 10.1542/peds.2007-1103.
10
Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.美国国立卫生研究院支气管肺发育不良共识定义的验证
Pediatrics. 2005 Dec;116(6):1353-60. doi: 10.1542/peds.2005-0249.
引用本文的文献
1
Prophylactic early low-dose hydrocortisone and survival without bronchopulmonary dysplasia among extremely preterm infants born at 22-27 weeks' gestation.22-27 孕周极早产儿预防性应用早期小剂量氢化可的松对支气管肺发育不良生存的影响。
J Perinatol. 2024 Jul;44(7):947-952. doi: 10.1038/s41372-024-01923-5. Epub 2024 Mar 8.
2
Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.评估极早产儿糖皮质激素治疗与死亡或残疾风险：基于治疗前死亡或支气管肺发育不良风险的评估。
JAMA Netw Open. 2023 May 1;6(5):e2312277. doi: 10.1001/jamanetworkopen.2023.12277.
3
Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia.美国国立卫生研究院儿童健康与人类发育研究所新生儿研究网络对支气管肺发育不良的诊断、预防和治疗的贡献。
Semin Perinatol. 2022 Nov;46(7):151638. doi: 10.1016/j.semperi.2022.151638. Epub 2022 Jun 10.
4
Lung disease and pulmonary hypertension in the premature infant.早产儿的肺部疾病与肺动脉高压
Prog Pediatr Cardiol. 2019 Sep;54. doi: 10.1016/j.ppedcard.2019.101135. Epub 2019 Jul 31.
5
Are all stem cells equal? Systematic review, evidence map, and meta-analyses of preclinical stem cell-based therapies for bronchopulmonary dysplasia.所有干细胞都一样吗？基于临床前干细胞疗法治疗支气管肺发育不良的系统评价、证据图谱和荟萃分析。
Stem Cells Transl Med. 2020 Feb;9(2):158-168. doi: 10.1002/sctm.19-0193. Epub 2019 Nov 20.
6
Neonatal Dexamethasone Treatment Suppresses Hippocampal Estrogen Receptor α Expression in Adolescent Female Rats.新生儿地塞米松治疗抑制青春期雌性大鼠海马雌激素受体 α 的表达。
Mol Neurobiol. 2019 Mar;56(3):2224-2233. doi: 10.1007/s12035-018-1214-6. Epub 2018 Jul 13.
7
Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.间质基质细胞疗法在支气管肺发育不良中的应用：临床前研究的系统评价和荟萃分析。
Stem Cells Transl Med. 2017 Dec;6(12):2079-2093. doi: 10.1002/sctm.17-0126. Epub 2017 Oct 17.
本文引用的文献
1
Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.在一项随机试验中，早期使用地塞米松预防极低出生体重儿死亡或慢性肺部疾病，以校正年龄 18 至 22 个月时的死亡或神经发育损伤。
J Pediatr. 2014 Jan;164(1):34-39.e2. doi: 10.1016/j.jpeds.2013.07.027. Epub 2013 Aug 27.
2
Obstetric and neonatal care practices for infants 501 to 1500 g from 2000 to 2009.2000 年至 2009 年间，501 至 1500 克婴儿的产科和新生儿护理实践。
Pediatrics. 2013 Aug;132(2):222-8. doi: 10.1542/peds.2013-0501. Epub 2013 Jul 15.
3
Truths, associations, and hypotheses.
J Pediatr. 2011 Sep;159(3):359-61. doi: 10.1016/j.jpeds.2011.05.002. Epub 2011 Jun 16.
4
Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.预测极早产儿支气管肺发育不良的出生后年龄。
Am J Respir Crit Care Med. 2011 Jun 15;183(12):1715-22. doi: 10.1164/rccm.201101-0055OC. Epub 2011 Mar 4.
5
Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.出生后早期（<8天）使用皮质类固醇预防早产儿慢性肺病
Cochrane Database Syst Rev. 2010 Jan 20(1):CD001146. doi: 10.1002/14651858.CD001146.pub3.
6
Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants.晚期（>7天）产后使用皮质类固醇治疗早产儿慢性肺病
Cochrane Database Syst Rev. 2009 Jan 21(1):CD001145. doi: 10.1002/14651858.CD001145.pub2.
7
Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.基于证据的极低出生体重儿预防支气管肺发育不良的新生儿药物治疗。
Neonatology. 2008;93(4):284-7. doi: 10.1159/000121453. Epub 2008 Jun 5.
8
Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.DART研究中2岁婴儿的结局：一项低剂量地塞米松的多中心、国际、随机对照试验
Pediatrics. 2007 Apr;119(4):716-21. doi: 10.1542/peds.2006-2806.
9
Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks.3个大型新生儿网络中用于支气管肺发育不良的产后类固醇使用情况的变化。
Pediatrics. 2006 Nov;118(5):e1328-35. doi: 10.1542/peds.2006-0359.
10
Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.低剂量地塞米松有助于长期依赖呼吸机的婴儿脱机：一项多中心、国际、随机、对照试验。
Pediatrics. 2006 Jan;117(1):75-83. doi: 10.1542/peds.2004-2843.
Zotero 插件